 |
|
|
|
|
|
Treatment |
|
Location |
|
Last Updated |
|
|
|
Details |
|
A Phase II Trial of Thalidomide in combination with Temozolomide or CPT-11 in patients with recurrent anaplastic gliomas or glioblastoma multiforme
|
|
Houston, TX |
|
10/27/2008 |
|
|
|
|
|
Details |
|
Phase I Trial of Aflibercept (VEGF Trap)with Radiation Therapy and Concomitant and Adjuvant Temozolomide in Patients With Malignant Gliomas |
|
Los Angeles, CA
San Francisco, CA
Boston, MA
Bethesda, MD
Durham, NC
New York, NY
Pittsburgh, PA
Houston, TX
San Antonio, TX
Madison, WI |
|
10/27/2008 |
|
|
|
Details |
|
A Phase 1, Open-Label, Dose Escalation Study of ANG1005 in Patients With Malignant Glioma
|
|
Boston, MA
New York, NY
Houston, TX
Charlottesville, VA |
|
10/09/2008 |
|
|
|
|
|
Details |
|
Erlotinib and Temozolomide With Radiation Therapy in Treating Patients With Glioblastoma Multiforme or Other Brain Tumors |
|
Charlottesville, VA |
|
09/30/2008 |
|
|
|
Details |
|
Gliogene: An International Brain Tumor Study |
|
Houston, TX |
|
07/24/2008 |
|
|
|
|
|
Details |
|
Phase I/II Trial of Irinotecan plus Lenalidomide in Adult Patients with Recurrent Glioblastoma Multiforme |
|
Houston, TX |
|
05/28/2008 |
|
|
|
Details |
|
Phase 1, Open-Label, Dose Escalation Study of ANG1005 in Patients with Malignant Glioma |
|
Houston, TX |
|
05/28/2008 |
|
|
|
|
|
Details |
|
A Randomized Phase II Trial of Bevacizumab With Irinotecan or Bevacizumab With Temozolomide in Recurrent Glioblastoma
|
|
Houston, TX |
|
04/15/2008 |
|
|
|
Details |
|
Phase I / II Adaptive Randomized Trial of Vorinostat, Isotretinoin and Carboplatin in Adults with Recurrent Glioblastoma Multiforme
|
|
Houston, TX |
|
04/15/2008 |
|
|
|
|
|
Details |
|
Phase I/II Study of OSI-774 (Erlotinib) and CCI-779 (Temsirolimus) in Patients with Recurrent Malignant Glioma
|
|
Houston, TX |
|
04/15/2008 |
|
|
|
Details |
|
A Phase I Study of Vorinostat [Suberoylanilide Hydroxamic Acid (SAHA)] in Combination with Temozolomide in Patients with Malignant Gliomas |
|
Los Angeles, CA
Boston, MA
Bethesda, MD
Durham, NC
New York, NY
Houston, TX |
|
04/15/2008 |
|
|
|
|
|
Details |
|
Phase I/II Studies of BAY 43-9006 (Sorafenib) in Combination With OSI-774 (Erlotinib), R115777 (Tipifarnib) or CCI-779 (Temsirolimus) in Patients With Recurrent Glioblastoma Multiforme or Gliosarcoma |
|
Los Angeles, CA
Boston, MA
Bethesda, MD
Durham, NC
New York, NY
Pittsburgh, PA
Houston, TX
Houston, TX
San Antonio, TX
Madison, WI |
|
04/15/2008 |
|
|
|
Details |
|
A Phase l Trial of Surgical Resection With Gliadel Wafer Placement Followed by Vaccination With Dendritic Cells Pulsed With Tumor Lysate for Patients With Malignant Glioma
|
|
Los Angeles, CA |
|
03/02/2008 |
|
|
|
|
|
Details |
|
Phase I Study of Immunization With Autologous Tumor Lysate-Pulsed Dendritic Cells in Patients With Malignant Gliomas (Vaccine Therapy in Treating Patients With Malignant Glioma) |
|
Los Angeles, CA |
|
03/02/2008 |
|
|
|
Details |
|
Phase I/II Study of GP96 Heat Shock Protein-Peptide Complex Vaccine in Patients With Recurrent or Progressive High-Grade Glioma |
|
San Francisco, CA |
|
03/02/2008 |
|
|
|
|
|
Details |
|
Phase ll Trial of Tumor Lysate-Pulsed Dendritic Cell Immunotherapy for Patients With Atypical or Malignant, Primary or Metastatic Brain Tumors of the Central Nervous System |
|
Los Angeles, CA |
|
03/02/2008 |
|
|
|
Details |
|
A phase I/II Evaluation of Vaccination with Type-1 Dendritic Cells Pulsed With Multiple Peptides In the Treatment of HLA-A2 Positive Patients With Recurrent Malignant Gliomas |
|
Pittsburgh, PA |
|
03/02/2008 |
|
|
|
|
|
Details |
|
NTI 0501: An Open-Labeled, Extended-Use of Human Corticotropin-Releasing Factor (hCRF) (Xerecept) Intended for Patients Who Participate in Dexamethasone-Sparing Studies NTI 0302 or NTI 0303 |
|
Kingston, Ontario, CANADA
Edmonton, Alberta, CANADA
Halifax, Nova Scotia, Canada
Moncton, New Brunswick, CANADA
Ottawa, Ontario, CANADA
Toronto, Ontario, CANADA
Winnipeg, Manitoba, CANADA
Phoenix, AZ
La Jolla, CA
Palo Alto, CA
Sacramento, CA
Aurora, CO
Englewood, CO
Jacksonville, FL
Orlando, FL
Chicago, IL
Evanston, IL
Boston, MA
Detroit, MI
Winston-Salem, NC
Edison, NJ
Buffalo, NY
Columbus, OH
Columbus, OH
Portland, OR
Memphis, TN
Nashville, TN
Seattle, WA
Madison, WI |
|
03/01/2008 |
|
|
|
Details |
|
Gliogene: Brain Tumor Linkage Study |
|
San Francisco, CA
Tampa, FL
Boston, MA
New York, NY
Houston, Tx |
|
01/17/2008 |
|
|
|
|
|
Details |
|
Phase II Study Of 7 Days On/7 Days Off Temozolomide In Patients With High-Grade Glioma |
|
San Francisco, CA |
|
01/17/2008 |
|
|
|
Details |
|
NABTC 04-03: A Phase I Study of Vorinostat (Suberolyanilide Hydroxamic Acid [SAHA]) in Combination with Temozolomide in Patients with Malignant Gliomas |
|
San Francisco, CA |
|
10/03/2007 |
|
|
|
|
|
Details |
|
Phase I/II trial of Heat Shock Protein Peptide Complex-96 (HSPPC-96) Vaccine For Patients With Recurrent High Grade Glioma |
|
San Francisco, CA |
|
10/03/2007 |
|
|
|
Details |
|
NABTC 04-02: Erlotinib and Temsirolimus in Treating Patients With Recurrent Malignant Glioma
|
|
Los Angeles, CA
San Francisco, CA
Boston, MA
Durham, NC
New York, NY
Pittsburgh, PA
Houston, TX
San Antonio, TX
Madison, WI |
|
10/03/2007 |
|
|
|
|
|
Details |
|
Phase 1/2 Study of Enzastaurin plus Temozolomide
During and Following Radiation Therapy in Patients with
Newly Diagnosed Glioblastoma Multiforme or
Gliosarcoma |
|
San Francisco, CA |
|
10/03/2007 |
|
|
|
Details |
|
Phase I/II Studies of BAY 43-9006 (sorafenib) in Combination with OSI-774 (erlotinib), R115777 (tipifarnib) or CCI-779 (temsirolimus) in Patients with Recurrent Glioblastoma Multiforme or Gliosarcoma. |
|
San Francisco, CA |
|
10/03/2007 |
|
|
|
|
|
Details |
|
A Pharmacokinetic and Phase 2 Study of Sunitinib Malate in Recurrent Malignant Gliomas |
|
Toronto, Ontario, CANADA
New York, NY
Cincinnati,, OH
Columbus, OH |
|
08/26/2007 |
|
|
|
Details |
|
A Phase 2 Study of O-Benzylguanine (O6-BG) and Temozolomide in Patients With Glioblastoma Progressing at Least 3 Months After Completion of Primary Treatment With Radiation Therapy and Temozolomide |
|
Bethesda, MD |
|
08/26/2007 |
|
|
|
|
|
Details |
|
A Phase I/II Study of ATN-161 and Carboplatin in Adult Patients With Recurrent Intracranial Malignant Glioma |
|
Bethesda, MD |
|
08/26/2007 |
|
|
|
Details |
|
Phase 1/2 Study of Enzastaurin Plus Temozolomide During and Following Radiation Therapy in Patients With Newly Diagnosed Glioblastoma Multiforme or Gliosarcoma |
|
, |
|
08/26/2007 |
|
|
|
|
|
Details |
|
Phase I/II Study of Fractionated CyberKnife Stereotactic Radiosurgery for High Grade Gliomas in Elderly Patients With Poor Performance Status |
|
Boston, MA |
|
08/26/2007 |
|
|
|
Details |
|
A Phase I Study of Imatinib Mesylate (Gleevec) in Combination With Temozolomide (Temodar) in Patients With Malignant Glioma |
|
Durham, NC |
|
08/20/2007 |
|
|
|
|
|
Details |
|
A Phase II Safety Study of Bevacizumab in Patients With Multiple Recurrent or Progressive Malignant Gliomas |
|
Chicago, IL |
|
08/20/2007 |
|
|
|
Details |
|
Eligibility Screening Of Patients With Central Nervous System Tumors For The National Cancer Institute`s (NCI) Clinical Research Protocols |
|
Bethesda, MD |
|
08/20/2007 |
|
|
|
|
|
Details |
|
Phase II Study of Intrathecal I-3F8 in Patients With GD2-Expressing Central Nervous System and Leptomeningeal Neoplasms |
|
New York, NY |
|
08/20/2007 |
|
|
|
Details |
|
A Phase II Trial of Bevacizumab (Avastin) and Irinotecan (CPT-11) for Patients With Recurrent High-Grade Gliomas Immediately Following Tumor Progression After Treatment With Bevacizumab Alone |
|
Bethesda, MD |
|
08/19/2007 |
|
|
|
|
|
Details |
|
Phase II Study of Dose Intensive Temozolomide (Temodar) in Elderly Adults With Newly Diagnosed Glioblastoma |
|
Tampa, FL |
|
08/19/2007 |
|
|
|
Details |
|
A Phase II Trial of BEVACIZUMAB for Patients with Recurrent High-Grade Gliomas |
|
Bethesda, MD |
|
08/18/2007 |
|
|
|
|
|
Details |
|
A Phase II Trial With Bevacizumab (Avastin) and Irinotecan (CPT-11) for Patients With Primary Brain Tumors and Progression After Standard Therapy |
|
Copenhagen, Denmark |
|
08/18/2007 |
|
|
|
Details |
|
Changes in Semen or Sperm Caused by Temozolomide in Patients With Newly Diagnosed, Progressive, or Recurrent Primary Malignant Brain Tumors |
|
Winston-Salem, NC |
|
08/18/2007 |
|
|
|
|
|
Details |
|
Phase I study of Gefitinib plus Rapamycin for patients with recurrent malignant glioma. |
|
Los Angeles, CA
Durham, NC |
|
08/18/2007 |
|
|
|
Details |
|
Brain Mapping for Brain Tumors |
|
Boston, MA |
|
08/18/2007 |
|
|
|
|
|
Details |
|
Functional image guided removal of brain tumors |
|
Manhasset, NY |
|
08/18/2007 |
|
|
|
Details |
|
Gliadel and Dendritic Cell Vaccine for Malignant Glioma |
|
Los Angeles, CA |
|
08/18/2007 |
|
|
|
|
|
Details |
|
Cilengitide and Radiation Therapy in Treating Patients With Newly Diagnosed Glioblastoma Multiforme |
|
Birmingham, AL
Tampa, FL
Boston, MA
Baltimore, MD
Detroit, MI
Winston-Salem, NC
Cleveland, OH
Philadelphia, PA |
|
05/01/2007 |
|
|
|
Details |
|
Evaluation of a Stress Reduction Program in Patients With Malignant Brain Tumors and Their Family Caregivers |
|
Cleveland, OH |
|
05/01/2007 |
|
|
|
|
|
Details |
|
Phase I Evaluation of Sodium Stibogluconate in Combination With Interferon a-2b for Solid Tumors, Lymphoma or Myeloma |
|
Cleveland, OH |
|
05/01/2007 |
|
|
|
Details |
|
Sorafenib in Treating Patients With Recurrent or Progressive Malignant Glioma
|
|
Detroit, MI |
|
05/01/2007 |
|
|
|
|
|
Details |
|
RTA 744 in Treating Patients With Recurrent or Refractory Anaplastic Astrocytoma, Anaplastic Oligodendroglioma, Anaplastic Mixed Oligoastrocytoma, Glioblastoma Multiforme, or Gliosarcoma |
|
Los Angeles, CA
Dallas, TX |
|
11/21/2006 |
|
|
|
Details |
|
Phase I/II Trial of Oral Erlotinib (Tarceva, OSI-774) for Treatment of Relapsed/Refractory Glioblastoma Multiforme and Anaplastic Astrocytoma
|
|
New York, NY |
|
10/12/2006 |
|
|
|
|
|
Details |
|
Erlotinib and Temozolomide With Radiation Therapy in Treating Patients With Glioblastoma Multiforme or Other Brain Tumors |
|
Birmingham, AL
Scottsdale/Phoenix, AZ
Jacksonville, FL
Cedar Rapids, IA
Des Moines, IA
Missouri Valley, IA
Sioux City, IA
Moline, IL
Peoria, IL
Urbana, IL
Wichita, KS
Rochester, MN
Saint Cloud, MN
Bismarck, ND
Fargo, ND
Lincoln, NE
Allentown, PA |
|
06/26/2006 |
|
|
|
Details |
|
A Phase I/II Trial of ZD6474 for Patients with Recurrent High-Grade and Progressive Low-Grade Gliomas |
|
Bethesda, MD |
|
05/29/2006 |
|
|
|
|
|
Details |
|
Phase I/II Study of High Dose Irinotecan (Camptosar, CPT-11) in Patients With Recurrent Unresectable Malignant Glioma on Steroids/Anti-Epileptics |
|
Louisville, KY |
|
05/29/2006 |
|
|
|
Details |
|
Pilot Randomized Study of Modafinil for Treatment of Fatigue and Neurobehavioral Dysfunction in Patients With Primary Brain Tumors |
|
Los Angeles, CA |
|
05/29/2006 |
|
|
|
|
|
Details |
|
A Phase II Study of Radiation With Concomitant and Then Sequential Temozolomide in Patients With Newly Diagnosed Supratentorial Malignant Glioma Who Have Undergone Surgery With Gliadel Wafer Insertion |
|
Louisville, KY |
|
05/27/2006 |
|
|
|
Details |
|
Lenalidomide in Treating Young Patients With Recurrent, Progressive, or Refractory CNS Tumors |
|
Washington, DC
Chicago, IL
Boston, MA
Bethesda, MD
Philadelphia, PA
Pittsburgh, PA
Memphis, TN
Houston, TX
Seattle, WA |
|
05/27/2006 |
|
|
|
|
|
Details |
|
Comparative 2-D Tumor Analysis in Familial Gliomas |
|
Edmonton, Alberta, Canada |
|
05/04/2006 |
|
|
|
Details |
|
A Phase I/II Trial of Depsipeptide (FK228) in Patients with High-Grade Gliomas |
|
Bethesda, MD |
|
05/01/2006 |
|
|
|
|
|
Details |
|
A Phase II Trial of Tamoxifen and Bortezomib (Velcade) in Patients with Recurrent High-Grade Gliomas |
|
Bethesda, MD |
|
05/01/2006 |
|
|
|
Details |
|
A Pilot Study of Dronabinol for the treatment of nausea,vomiting and appetite loss in Adult Patients With Primary Gliomas |
|
Durham, NC |
|
05/01/2006 |
|
|
|
|
|
Details |
|
Phase I/II Study of ZD6474(Zactima) in Patients With Recurrent High-Grade or Progressive Low-Grade Gliomas |
|
Bethesda, MD |
|
05/01/2006 |
|
|
|
Details |
|
Phase II Study of Pemetrexed Disodium (Alimta) in Patients With Recurrent Malignant Gliomas, Primary CNS Lymphoma, or Brain Metastases |
|
Chicago, IL |
|
05/01/2006 |
|
|
|
|
|
Details |
|
Pilot Study of the Safety and Accuracy of Fluorothymidine F 18 Positron Emission Tomography in Detecting Recurrent Disease in Patients With Gliomas
|
|
Seattle, WA |
|
05/01/2006 |
|
|
|
Details |
|
Headstart II A Phase II study of two alternative intensive induction chemotherapy followed by consolidation with myeloablative chemotherapy and autologous stem cell rescue with or without
subsequent radiation therapy for children less than 10 yrs of age newly diagnosed with malignant brain tumors |
|
Oakland, CA |
|
05/01/2006 |
|
|
|
|
|
Details |
|
Phase II Study of O6-Benzylguanine and Temozolomide (Temodar) in Pediatric Patients With Recurrent or Progressive High-Grade Gliomas or Brain Stem Tumors |
|
Chicago, IL
Bethesda, MD
Bethesda, MD
Durham, NC
Durham, NC
Lincoln, NE
Philadelphia, PA
Memphis, TN
Houston, TX
Seattle, WA |
|
05/01/2006 |
|
|
|
Details |
|
Bevacizumab in Treating Patients With Recurrent Glioma |
|
Bethesda, MD |
|
04/30/2006 |
|
|
|
|
|
Details |
|
Temozolomide Plus Peripheral Stem Cell Transplantation in Treating Children With Newly Diagnosed Malignant Glioma or Recurrent CNS or Other Solid Tumors |
|
Durham, NC |
|
12/04/2005 |
|
|
|
Details |
|
Phase II trial of Temodar ® plus O6-Benzylguanine in the treatment of patients with Temodar® -resistant malignant glioma.
|
|
Durham, NC |
|
12/03/2005 |
|
|
|
|
|
Details |
|
Pharmacological intervention for learning impaired children surviving treatment for cancer. |
|
Durham, NC |
|
12/03/2005 |
|
|
|
Details |
|
Gamma Knife Radiosurgery |
|
Smithtown, NY |
|
12/03/2005 |
|
|
|
|
|
Details |
|
Gamma Knife Radiosurgery for Brain Tumors |
|
La Jolla, CA |
|
12/03/2005 |
|
|
|
Details |
|
Phase I trial of Temodar plus O6-Benzylguanine plus Irinotecan (CPT-11) in the treatment of patients with recurrent/progressive Cerebral anaplastic gliomas. |
|
Durham, NC |
|
12/03/2005 |
|
|
|
|
|
Details |
|
A Phase I dose escalation trial of Temodar that will attempt to determine the maximum tolerated dose of Temodar (Temozolomide) when given by prolonged oral exposure to children with recurrent or progressive brain tumors. |
|
New York, NY |
|
12/03/2005 |
|
|
|
Details |
|
Fractionated Stereotactic Radiosurgery plus Topotecan radiation sensitizer in the treatment of recurrent malignant astrocytoma or as consolidation after external beam radiotherapy. |
|
New York, NY |
|
12/03/2005 |
|
|
|
|
|
Details |
|
Gamma Knife Radiosurgery |
|
Edison, NJ |
|
12/03/2005 |
|
|
|
Details |
|
Gamma knife stereotactic radiosurgery for benign and malignant brain tumors and brain metastases. |
|
Rockville Centre, NY |
|
12/03/2005 |
|
|
|
|
|
Details |
|
Quality of Life Studies (There are 19 seperate studies listed here) |
|
Durham, NC |
|
12/03/2005 |
|
|
|
Details |
|
A Phase I Trial of CC-8490 for the Treatment of Patients with Recurrent/Refractory High-Grade Gliomas |
|
Bethesda, MD |
|
11/27/2005 |
|
|
|
|
|
Details |
|
Acetylcysteine, Mannitol, Combination Chemotherapy, and Sodium Thiosulfate in Treating Children With Malignant Brain Tumors |
|
Portland, OR |
|
11/27/2005 |
|
|
|
Details |
|
Melphalan and Mannitol in Treating Patients With Central Nervous System Tumors |
|
Portland, OR |
|
11/27/2005 |
|
|
|
|
|
Details |
|
Phosphorus 32 in Treating Patients With Glioblastoma Multiforme
|
|
Garden City, NY |
|
11/27/2005 |
|
|
|
Details |
|
A Phase I, Molecular Biology, and Phase II Study of Lapatinib (GW572016) in Pediatric Patients with Recurrent or Refractory Medulloblastoma, Malignant Glioma or Ependymoma
|
|
Washington, DC
Chicago, IL
Boston, MA
Bethesda, MD
Durham, NC
Philadelphia, PA
Pittsburgh, PA
Memphis, TN
Memphis, TN
Houston, TX
Seattle, WA |
|
11/27/2005 |
|
|
|
|
|
Details |
|
Arsenic Trioxide and Radiation Therapy in Treating Young Patients With Newly Diagnosed Gliomas (Brainstem glioma, glioblastoma multiforme, gliosarcoma, anaplastic astrocytoma)
|
|
Baltimore, MD |
|
11/27/2005 |
|
|
|
Details |
|
Computer Assisted Stereotactic Navigation For Resection Of Brain Tumors In Children And Adults |
|
Hackensack, NJ |
|
11/27/2005 |
|
|
|
|
|
Details |
|
Double sequential high dose Thiotepa with autologous stem cell rescue for patients age <60 years with recurrent malignant brain cancer. |
|
Los Angeles, CA |
|
11/27/2005 |
|
|
|
Details |
|
Endoscopic ventriculostomy for obstructive hydrocephalus in terminal patients with hydrocephalus and brain tumours. |
|
Kelantan, Malaysia, MALAYSIA |
|
11/27/2005 |
|
|
|
|
|
Details |
|
Functional brain Mapping Of Motor And Speech Areas For Resection Of Tumors Near Functional Areas Of The Brain |
|
Hackensack, NJ |
|
11/27/2005 |
|
|
|
Details |
|
Phase 2 Trial of Stereotactic Radiosurgery For Recurrent Pediatric Brain Tumors |
|
Hackensack, NJ |
|
11/27/2005 |
|
|
|
|
|
Details |
|
A Phase II Trial of Cisplatinum and Temodar followed by Cranial Irradiation and Temodar in Adults with Newly Diagnosed Glioblastoma Multiforme |
|
Rochester, NY |
|
11/26/2005 |
|
|
|
Details |
|
Adoptive IL-2 activated LAK cell intratumoral immunotherapy implant with adjuvant radiosurgery boost and naturopathic/nutritional immune enhancement. This is for newly diagnosed patients only.
|
|
Newport Beach, CA |
|
11/26/2005 |
|
|
|
|
|
Details |
|
Bio-Anatomic Radiation Treatment Planning for Newly Diagnosed
Glioblastoma multiforme |
|
Winston-Salem, NC |
|
11/26/2005 |
|
|
|
Details |
|
Gamma Knife Radiosurgery for Brain Tumors and Arteriovenous and Cavernous Malformations |
|
St.Petersburg, Fl |
|
11/26/2005 |
|
|
|
|
|
Details |
|
Intra-arterial carboplatin for supratentorial brain tumors |
|
Fort Worth, TX |
|
11/26/2005 |
|
|
|
Details |
|
Aggresive emergency tumour debulking and craniectomy for patients with tumours of more than 80ml and glasgow coma scale of less than 8. |
|
Kelantan, Malaysia, MALAYSIA |
|
11/26/2005 |
|
|
|
|
|
Details |
|
Chemosensitivity assay for malignant brain tumors |
|
Huntington Beach, CA |
|
11/26/2005 |
|
|
|
Details |
|
Computer assisted minimally invasive image guided surgery for improved resection of malignant brain tumors and frameless stereotactic brain biopsies For Deep Brain Tumors. |
|
Smithtown, NY |
|
11/26/2005 |
|
|
|
|
|
Details |
|
Concurrent Temozolomide and Radiotherapy Followed By Dose Dense Versus Metronomic Temozolomide and Maintenance Cis-Retinoic Acid For Patients With Newly Diagnosed Glioblastoma And Other Malignant Gliomas |
|
New York, NY |
|
11/26/2005 |
|
|
|
Details |
|
Conventional Radiation Therapy + Thalidomide for Supratentorial Glioblastoma |
|
Winston-Salem, NC |
|
11/26/2005 |
|
|
|
|
|
Details |
|
Dose Escalation Study of RT Using 3-Dimensional Treatment Planning for Newly Diagnosed GBM |
|
Winston-Salem, NC |
|
11/26/2005 |
|
|
|
Details |
|
Headstart II A Phase II study of two alternative intensive induction chemotherapy followed by consolidation with myeloablative chemotherapy and autologous stem cell rescue with or without
subsequent radiation therapy for children less than 10 yrs of age newly diagnosed with malignant brain tumors |
|
New York, NY |
|
11/26/2005 |
|
|
|
|
|
Details |
|
Intraoperative navigation in neurosurgical patients |
|
Boston, MA |
|
11/26/2005 |
|
|
|
Details |
|
Phase I/II Trial of Temodar and Escalating Doses of Oral VP-16 for Patients with Recurrent Malignant Glioma |
|
Rochester, NY |
|
11/26/2005 |
|
|
|
|
|
Details |
|
Reliable Imaging Diagnosis of Recurrent Brain Tumor |
|
Winston-Salem, NC |
|
11/26/2005 |
|
|
|
Details |
|
Frameless Computer Assisted Stereotactic Surgery for Resection of Brain Tumors in Adults and Children |
|
Rockford, IL |
|
11/25/2005 |
|
|
|
|
|
Details |
|
Frameless Computer Guided Stereotactic Sugery for Resection of Brain Tumors in Adults and Children |
|
Rockford, IL |
|
